|
|
Volumn 12, Issue 10, 2001, Pages 1417-1422
|
|
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
a
|
|
Author keywords
Gemcitabine; Ifosfamide; Metastatic urothelial cancer; Salvage chemotherapy
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
GEMCITABINE;
GROWTH FACTOR;
IFOSFAMIDE;
MESNA;
TAXANE DERIVATIVE;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSURIA;
FEMALE;
FEVER;
HEMATURIA;
HOSPITALIZATION;
HUMAN;
HUMAN TISSUE;
LEG EDEMA;
MALE;
MEDICAL SOCIETY;
METASTASIS;
NAUSEA;
NEUTROPENIA;
PAIN;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROPHYLAXIS;
SALVAGE THERAPY;
STATISTICAL ANALYSIS;
SYMPTOMATOLOGY;
THROMBOCYTOPENIA;
UROGENITAL TRACT CANCER;
AGED;
ANEMIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
FEMALE;
HEMATURIA;
HUMANS;
IFOSFAMIDE;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEUTROPENIA;
PAIN;
SALVAGE THERAPY;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
URINATION DISORDERS;
UROLOGIC NEOPLASMS;
|
|
EID: 0035182824
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012599307090 Document Type: Article |
|
Times cited : (34)
|
|
References (25)
|
